IART vs XLI
Integra LifeSciences Holdings (IART) versus XLI (XLI) — a side-by-side from cached financials, not a winner call.
Integra LifeSciences Holdings (IART) is a medical devices company listed on US.
XLI (XLI) common stock.
Latest reported IART revenue for 2025-12-31 was $1.64B. Net income was -$516.5M. IART currently screens at market cap $1.32B.
XLI does not have a complete income-statement cache yet.
IART currently screens at market cap $1.32B. XLI currently screens at market cap $0.
Not investment advice. Open the IART and XLI stock pages for the full models.
Not investment advice.